# Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia

> **NCT01850940** · — · COMPLETED · sponsor: **Beijing Friendship Hospital** · enrollment: 98 (actual)

## Conditions studied

- Liver Cirrhosis
- Hyponatremia

## Interventions

- **DRUG:** Tolvaptan
- **OTHER:** conventional thearpy

## Key facts

- **NCT ID:** NCT01850940
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-09
- **Final completion:** 2015-05
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850940, "Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01850940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*